GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » ROA %

Sinopharm Tech Holdings (HKSE:08156) ROA % : -4.61% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Sinopharm Tech Holdings's annualized Net Income for the quarter that ended in Dec. 2023 was HK$-2.13 Mil. Sinopharm Tech Holdings's average Total Assets over the quarter that ended in Dec. 2023 was HK$46.23 Mil. Therefore, Sinopharm Tech Holdings's annualized ROA % for the quarter that ended in Dec. 2023 was -4.61%.

The historical rank and industry rank for Sinopharm Tech Holdings's ROA % or its related term are showing as below:

HKSE:08156' s ROA % Range Over the Past 10 Years
Min: -88.99   Med: -48.18   Max: 4.73
Current: -64.75

During the past 13 years, Sinopharm Tech Holdings's highest ROA % was 4.73%. The lowest was -88.99%. And the median was -48.18%.

HKSE:08156's ROA % is ranked worse than
91.12% of 2825 companies
in the Software industry
Industry Median: 1.05 vs HKSE:08156: -64.75

Sinopharm Tech Holdings ROA % Historical Data

The historical data trend for Sinopharm Tech Holdings's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings ROA % Chart

Sinopharm Tech Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.16 -77.28 -65.63 -82.71 -19.27

Sinopharm Tech Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.25 -46.59 -235.59 -27.99 -4.61

Competitive Comparison of Sinopharm Tech Holdings's ROA %

For the Software - Application subindustry, Sinopharm Tech Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's ROA % Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's ROA % distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's ROA % falls into.



Sinopharm Tech Holdings ROA % Calculation

Sinopharm Tech Holdings's annualized ROA % for the fiscal year that ended in Jun. 2023 is calculated as:

ROA %=Net Income (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=-10.635/( (76.886+33.482)/ 2 )
=-10.635/55.184
=-19.27 %

Sinopharm Tech Holdings's annualized ROA % for the quarter that ended in Dec. 2023 is calculated as:

ROA %=Net Income (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=-2.132/( (0+46.23)/ 1 )
=-2.132/46.23
=-4.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Dec. 2023) net income data. ROA % is displayed in the 30-year financial page.


Sinopharm Tech Holdings  (HKSE:08156) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-2.132/46.23
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-2.132 / 59.412)*(59.412 / 46.23)
=Net Margin %*Asset Turnover
=-3.59 %*1.2851
=-4.61 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Sinopharm Tech Holdings ROA % Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines